{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:16:49Z","timestamp":1782537409317,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","award":["50706"],"award-info":[{"award-number":["50706"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118165","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:53:16Z","timestamp":1758023596000},"page":"118165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Microwave-assisted one-pot green synthesis, ADMET profiling, DFT, and molecular docking of novel 3-cyano-2-pyridone derivatives as dual EGFR and cytokine (TNF-\u03b1, IL-6) inhibitors"],"prefix":"10.1016","volume":"300","author":[{"given":"Eslam M.","family":"Lotfy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"Bokhtia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan A.","family":"Abdel Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-4017","authenticated-orcid":false,"given":"Israa A.","family":"Seliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118165_bib1","doi-asserted-by":"crossref","first-page":"32309","DOI":"10.1039\/D5RA04722F","article-title":"Design, eco-friendly synthesis, and molecular docking studies of isatin hybrids as promising therapeutic agents (anticancer, anticholinesterase inhibitor, \u03b1-glucosidase inhibitor, and anti-MRSA)","volume":"15","author":"Seliem","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118165_bib2","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1096\/fj.07-8832com","article-title":"Interleukin\u20106 is a potent growth factor for ER\u2010\u03b1\u2010positive human breast cancer","volume":"21","author":"Sasser","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118165_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1210\/me.2011-1302","article-title":"Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers","volume":"26","author":"Baumgarten","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118165_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Esquivel-Vel\u00e1zquez","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejmech.2025.118165_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225383","article-title":"Cytokine profile in lung cancer patients: anti-tumor and oncogenic cytokines","volume":"15","author":"Essogmo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118165_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging Diagnostic devices for cancer detection and Prognosis","volume":"11","author":"Kartikasari","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118165_bib7","series-title":"Professor of Oncologic Sciences and Pharmacology","author":"Piazza","year":"2011"},{"key":"10.1016\/j.ejmech.2025.118165_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/156802607779941224","article-title":"Re-discovering PDE3 inhibitors - new opportunities for a long Neglected target","volume":"7","author":"Thompson","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1570180816666190220123547","article-title":"New 2-Oxopyridine\/2-Thiopyridine derivatives tethered to a Benzotriazole with cytotoxicity on MCF7 cell lines and with antiviral activities","volume":"17","author":"Attia","year":"2020","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2025.118165_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103481","article-title":"Apoptosis: a target for anticancer therapy with novel cyanopyridines","volume":"94","author":"Ismail","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137309","article-title":"Synthesis and antitumorigenesis effect of novel 2-amino -3-cyano pyridine derivatives containing sulfonamide moiety against breast cancer","volume":"1301","author":"Zailaee","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118165_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jhet.2593","article-title":"O \u2010Glycosylation\/Alkylation and antimicrobial activity of 4,6\u2010Diaryl\u20102\u2010Oxonicotinonitrile derivatives","volume":"54","author":"Haggam","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib13","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1016\/j.bmc.2005.05.027","article-title":"Lewis acid-promoted transformation of 2-alkoxypyridines into 2-aminopyridines and their antibacterial activity. Part 2: Remarkably facile C\u2013N bond formation","volume":"13","author":"Abdel-Aziz","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ardp.201500175","article-title":"Synthesis of some 1,4,6\u2010Trisubstituted\u20102\u2010oxo\u20101,2\u2010dihydropyridine\u20103\u2010carbonitriles and their biological evaluation as cytotoxic and antimicrobial agents","volume":"348","author":"Faidallah","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118165_bib15","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1039\/C5NJ03683F","article-title":"Polymorphic study and anti-inflammatory activity of a 3-cyano-2-pyridone based flexible model","volume":"40","author":"Rai","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3797\/scipharm.aut-05-15","article-title":"Synthesis and Antidepressant activity of some new Coumarin derivatives","volume":"73","author":"Abdel-Latif","year":"2005","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2025.118165_bib17","series-title":"Original Article Submitted","author":"Kui\u2019nevich","year":"1990"},{"key":"10.1016\/j.ejmech.2025.118165_bib18","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.3390\/ijms23105659","article-title":"Pyridine compounds with antimicrobial and antiviral activities","volume":"23","author":"Marinescu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118165_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137309","article-title":"Synthesis and antitumorigenesis effect of novel 2-amino -3-cyano pyridine derivatives containing sulfonamide moiety against breast cancer","volume":"1301","author":"Zailaee","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118165_bib20","first-page":"427","article-title":"Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters","volume":"47","author":"Mosti","year":"1992","journal-title":"Farmaco"},{"key":"10.1016\/j.ejmech.2025.118165_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0223-5234(92)90141-M","article-title":"Anti-inflammatory, analgesic and antipyretic 4,6-disubstituted 3-cyanopyridine-2-ones and 3-cyano-2-aminopyridines","volume":"27","author":"Manna","year":"1992","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib22","doi-asserted-by":"crossref","first-page":"34965","DOI":"10.1039\/D2RA07056A","article-title":"Bioactive 2-pyridone-containing heterocycle syntheses using multicomponent reactions","volume":"12","author":"Hurtado-Rodr\u00edguez","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118165_bib23","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1039\/C5NJ03683F","article-title":"Polymorphic study and anti-inflammatory activity of a 3-cyano-2-pyridone based flexible model","volume":"40","author":"Rai","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejmech.2013.10.018","article-title":"Synthesis, ex vivo and in silico studies of 3-cyano-2-pyridone derivatives with vasorelaxant activity","volume":"70","author":"Hern\u00e1ndez","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib25","doi-asserted-by":"crossref","first-page":"19351","DOI":"10.1021\/acsomega.2c08304","article-title":"Cyanopyridinone- and cyanopyridine-based cancer cell Pim-1 inhibitors: design, synthesis, Radiolabeling, Biodistribution, and molecular modeling simulation","volume":"8","author":"Mansour","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118165_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105564","article-title":"Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase\/HDAC inhibitors","volume":"119","author":"Bass","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104378","article-title":"New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: synthesis and SARs study","volume":"105","author":"Farrag","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/chin.200730108","article-title":"Identification and structure\u2014activity relationships of substituted pyridones as inhibitors of Pim\u20101 kinase","volume":"38","author":"Cheney","year":"2007","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2025.118165_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21608\/jabps.2020.52641.1113","article-title":"3-Cyano-2-oxa-pyridines: a promising template for diverse pharmacological activities","volume":"4","author":"Bass","year":"2021","journal-title":"Journal of Advanced Biomedical and Pharmaceutical Sciences"},{"key":"10.1016\/j.ejmech.2025.118165_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106874","article-title":"New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: synthesis, anticancer evaluation, and molecular modeling studies","volume":"141","author":"Hawas","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib31","doi-asserted-by":"crossref","first-page":"24928","DOI":"10.1039\/D4RA04563G","article-title":"Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1 H)-pyridones as potential anticancer agents","volume":"14","author":"Hurtado-Rodr\u00edguez","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118165_bib32","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.3390\/molecules28186586","article-title":"Design, synthesis, and biological evaluation of novel 3-Cyanopyridone\/Pyrazoline hybrids as potential apoptotic antiproliferative agents targeting EGFR\/BRAFV600E inhibitory pathways","volume":"28","author":"Al-Wahaibi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118165_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103358","article-title":"Design, synthesis, cytotoxicity screening and molecular docking of new 3-cyanopyridines as survivin inhibitors and apoptosis inducers","volume":"94","author":"Sabour","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib34","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.bmcl.2007.03.042","article-title":"Discovery of a novel small molecule binding site of human survivin","volume":"17","author":"Wendt","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118165_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1248\/cpb.c18-00269","article-title":"Design, synthesis and screening of 4,6-Diaryl pyridine and pyrimidine derivatives as potential cytotoxic molecules","volume":"66","author":"Abd elhameid","year":"2018","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.118165_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118165_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13091349","article-title":"The Crosstalk between the EGFR and IFN-\u03b3 pathways and synergistic roles in survival prediction and immune Escape in gliomas","volume":"13","author":"Zhou","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejmech.2025.118165_bib38","article-title":"Sustaining the activation of EGFR signal by inflammatory cytokine IL17A prompts cell proliferation and EGFR-TKI resistance in lung cancer","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118165_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.847534","article-title":"In vitro evaluation of antioxidant, anticancer, and anti-inflammatory activities of ethanolic leaf extract of adenium obesum","volume":"13","author":"Alshehri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118165_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114972","article-title":"Anticancer activity of thymoquinone against breast cancer cells: mechanisms of action and delivery approaches","volume":"165","author":"Shabani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118165_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103527","article-title":"Bazedoxifene plus conjugated estrogen to treat menopausal depression\u2014a pilot study","volume":"392","author":"Kulkarni","year":"2025","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.118165_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174285","article-title":"New contributions to the drug profile of TNF\u03b1 inhibitor SPD304: affinity, selectivity and ADMET considerations","volume":"907","author":"Mascret","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118165_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00098","article-title":"Design, synthesis, and evaluation of dihydrobenzo[cd]indole-6-sulfonamide as TNF-\u03b1 inhibitors","volume":"6","author":"Deng","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib44","doi-asserted-by":"crossref","first-page":"G805","DOI":"10.1152\/ajpgi.00522.2011","article-title":"TNF-\u03b1 induces upregulation of EGFR expression and signaling in human colonic myofibroblasts","volume":"302","author":"Yoo","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2025.118165_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1078766","article-title":"Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: perspectives in pharmacogenomics","volume":"13","author":"Lai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118165_bib46","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118165_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105155","article-title":"Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells","volume":"74","author":"Okamoto","year":"2021","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2025.118165_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"10.1016\/j.ejmech.2025.118165_bib49","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1089\/ars.2009.2611","article-title":"Redox regulation of tumor necrosis factor signaling","volume":"11","author":"Han","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2025.118165_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115320","article-title":"TBBPA causes inflammation and cell death via the ROS\/NF-\u03baB pathway in the gastric mucosa","volume":"262","author":"Xu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejmech.2025.118165_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118165_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0961-y","article-title":"Reactive oxygen species: a volatile driver of field cancerization and metastasis","volume":"18","author":"Liao","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118165_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107601","article-title":"DMF-DMA catalyzed Synthesis, molecular docking, in-vitro, in-silico design, and binding free energy studies of novel thiohydantoin derivatives as antioxidant and antiproliferative agents targeting EGFR tyrosine kinase and aromatase cytochrome P450 enzyme","volume":"150","author":"Seliem","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118165_bib54","doi-asserted-by":"crossref","first-page":"20495","DOI":"10.1039\/D5RA01257K","volume":"15","author":"Seliem","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118165_bib55","article-title":"Rapid generation of high-quality structure figures for publication with PyMOL-PUB","volume":"40","author":"Chen","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118165_bib56","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1021\/acs.jcim.0c01430","article-title":"Substituent effect on the Photophysics and ESIPT mechanism of N, N\u2032-Bis(salicylidene)-p-phenylenediamine: a DFT\/TD-DFT analysis","volume":"61","author":"Johnee Britto","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118165_bib57","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s11696-022-02123-1","article-title":"Coordination behavior, structural, statistical and theoretical investigation of biologically active metal-based isatin compounds","volume":"76","author":"Sumrra","year":"2022","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2025.118165_bib58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1134\/S1068162024030294","article-title":"In vitro antimicrobial, HCV, HBV, HAV, and breast cancer molecular docking Exploration of 6-[(E)-(4-Hydroxy-2,5-dinitrophenyl)diazenyl]-2H-chromen-2-one and 6-[(E)-(10-Hydroxy-9-anthryl)diazenyl]-2H-chromen-2-one","volume":"50","author":"Abdou","year":"2024","journal-title":"Russ. J. Bioorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:17:58Z","timestamp":1773112678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0223523425009304"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118165","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microwave-assisted one-pot green synthesis, ADMET profiling, DFT, and molecular docking of novel 3-cyano-2-pyridone derivatives as dual EGFR and cytokine (TNF-\u03b1, IL-6) inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118165"}}